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Peritonitis is a major complication of various disease entities
in internal medicine, surgery, and gynecology and, despite
treatment advances, remains associated with unacceptably
high morbidity and mortality. Causes of peritonitis are man-
ifold including infectious, autoimmune, or chemical pro-
cesses. A precise knowledge of inﬂammatory mechanisms in
the initiation and establishment of peritoneal inﬂammation
is of pivotal importance for the prevention and treatment of
peritonitis.
This special issue aims to bring the molecular mecha-
nisms of inﬂammatory processes in the peritoneal cavity into
focus,regardlessoftheorgansystemorthespeciﬁcsyndrome
they result from.
I nt h i ss p e c i a li s s u eo fMediators of Inﬂammation,w ea r e
pleased to present to the reader a series of special features
written by designated experts in the ﬁeld.
Local production of proinﬂammatory mediators at sites
of tissue and cell injury within the peritoneal membrane
plays a critical role in the propagation of peritoneal inﬂam-
mation. In addition to infectious causes, various forms of
peritoneal damage, induced by surgical trauma and peri-
tonealdialysis,compromiseperitonealintegrityandcanulti-
mately lead to tissue damage, ﬁbrosis, adhesions, or even
in the most severe cases the development of encapsulating
peritoneal sclerosis. Peritoneal mesothelial cells appear to
play a major role in these processes as they are capable
of expressing a raft of proinﬂammatory and immune-
modulatory mediators that either directly mediate ﬁbrotic
remodelling or attract immune cells to the peritoneal cavity
or participate in immune activation. Therapeutic modula-
tion of this sequence of events could provide novel avenues
to attenuate peritoneal inﬂammation and its resulting tissue
damage. The present special issue presents novel data on
this topic, particularly underscoring the potential impact
of the peroxisome proliferator-activated receptor-gamma
(PPAR-γ)inregulatingperitonealinﬂammationandﬁbrosis.
Furthermore, a novel PEGylated Toll-like receptor 7 (TLR7)
ligand might be of great value for treatment of mast-cell-
mediated neutrophilic inﬂammation.
M. W. J. A. Fieren describes the regulatory role of cyto-
kines, macrophages, and leukocytes during local inﬂamma-
tory processes in the peritoneal cavity. These processes are of
special interest in patients on peritoneal dialysis treatment.
A successful peritoneal dialysis treatment requires an intact
peritoneal membrane. Treatment can be complicated by
infectious or noninfectious sterile peritonitis due to the use
of nonphysiologic dialysis solutions. S. Yung and T. M. Chan
present an overview of pathophysiological changes to the
peritoneal membrane during peritonitis related to peritoneal
dialysis. G. Baroni et al. focus on structural changes during
peritoneal dialysis-related inﬂammation. Moreover, experi-
mental data presented in this special issue point to a novel
role of the osmosensitive transcription factor NFAT5 in
osmolality-induced expression of chemokines in human
mesothelialcells.Thisisofspecialinterestbecauseperitoneal
dialysis solutions are usually hypertonic. A rare but fatal
complication of peritoneal dialysis treatment is sclerosing
peritonitis; in their review article, M. Merkle and M. W¨ ornle2 Mediators of Inﬂammation
overview causes and treatment options, a complication
which can also be seen after kidney or liver transplantation.
Peritoneal adhesions frequently occur after abdominal
surgery.Patientswiththiscomplicationpresentwithabdom-
inal and pelvic pain or intestinal mechanical obstruction.
In this special issue, C. Di Filippo et al. provide evidence
for a pivotal role of the ubiquitin-proteasome system in the
formationofexperimentalpostsurgicalperitonealadhesions.
Furthermore, the authors show a possible therapeutic strat-
egytopreventadhesionformationbyblockingtheubiquitin-
proteasomesystem.W.Kessleretal.presentnoveldataonthe
particular importance of the vagus nerve for the pathophys-
iology of peritonitis. According to their data, a functioning
vagus nerve has a signiﬁcant modulating inﬂuence on mor-
tality in an animal model of polymicrobial sepsis.
Inthisspecialissue,T.Kelkka etal.presentdatainarthri-
tis and peritonitis mice models, where overexpression of
SOD3 results in anti-inﬂammatory eﬀects that are largely
independent of NOX2-mediated oxidative bursts. The anti-
inﬂammatory action of extracellular superoxide dismutase
(SOD3) is mediated by the dismutation of superoxide into
hydrogen peroxide. To analyze whether SOD3 can regulate
inﬂammation in the absence of functional NOX2 complex,
T. Kelkka et al. used an elegant design, comparing anti-
inﬂammatory eﬀects of overexpression of SOD3 in Ncf1−/−
mice with a deﬁcient oxidative burst with that in wild-type
mice. The relevance of these ﬁndings will need veriﬁcation
in the clinical setting; however, SOD3 is an important redox
regulatory enzyme, and polymorphisms in SOD3 gene are
associated with COPD, coronary artery disease, myocardial
infarction, and acute lung injury.
We would like to thank all contributors and reviewers for
their support to this special issue and feel sure that readers
will learn much about this important topic.
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